NIH Public Access Author Manuscript Cell. Author manuscript; available in PMC 2013 February 17. Published in final edited form as: Cell. 2012 February 17; 148(4): 739–751. doi:10.1016/j.cell.2011.12.031.
NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript
Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr -Virus Protein LMP1 in a Mouse Model Baochun Zhang1,11, Sven Kracker1,6,11, Tomoharu Yasuda1,7,11, Stefano Casola1,2,8,11, Matthew Vanneman3, Cornelia Hömig-Hölzel2,9, Zhe Wang1, Emmanuel Derudder1, Shuang Li1,10, Tirtha Chakraborty1, Shane E. Cotter4, Shohei Koyama3, Treeve Currie5, Gordon J. Freeman3, Jeffery L. Kutok5, Scott J. Rodig5, Glenn Dranoff3, and Klaus Rajewsky1,2,*,7 1Program of Cellular and Molecular Medicine, Children’s Hospital, and Immune Disease Institute, Harvard Medical School, Boston, MA 02115, USA 2Institute
for Genetics, University of Cologne, 50674 Cologne, Germany
3Department
of Medical Oncology and Cancer Vaccine Center, Dana-Farber Cancer Institute and Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02215, USA 4Department
of Radiation Oncology, Brigham and Women’s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA 5Department
of Pathology, Brigham and Women’s Hospital, Boston, MA 02115, USA
SUMMARY B cells infected by Epstein-Barr-Virus (EBV), a transforming virus endemic in humans, are rapidly cleared by the immune system, but some cells harboring the virus persist for life. Under conditions of immunosuppression EBV can spread from these cells and cause life threatening pathologies. We have generated mice expressing the transforming EBV latent membrane protein 1 (LMP1), mimicking a constitutively active CD40 coreceptor, specifically in B cells. Like human EBV infected cells, LMP1+ B cells were efficiently eliminated by T cells, and breaking immune surveillance resulted in rapid, fatal lymphoproliferation and lymphomagenesis. The lymphoma cells expressed ligands for a natural killer (NK) cell receptor, NKG2D, and could be targeted by an NKG2D-Fc fusion protein. These experiments indicate a central role for LMP1 in the surveillance and transformation of EBV infected B cells in vivo, establish a pre-clinical model for B cell lymphomagenesis in immunosuppressed patients, and validate a novel therapeutic approach.
© 2012 Elsevier Inc. All rights reserved. *
Correspondence: rajewsky@idi.harvard.edu. 6Present address: INSERM, U768, Hôpital Necker Enfants Malades, and Université Paris Descartes, Faculté de Médecine René Descartes, 75015 Paris, France 7Present address: Laboratory for Immune Regulation and Cancer, Max Delbrück Center for Molecular Medicine, 13092 Berlin, Germany 8Present address: IFOM-Fondazione Istituto FIRC di Oncologia Moleculare, 20139 Milan, Italy 9Present address: Division of Molecular Genetics, The Netherlands Cancer Institute, 1066CX Amsterdam, The Nether
lands 10Present address: Max Delbrück Center for Molecular Medicine, Berlin, Germany; Hematology, Oncology and Tumorimmunology, Charite, Medical University Berlin, 13353 Berlin, Germany 11These authors contributed equally to the work The authors declare no conflict of interest. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Molecular Properties of the Epstein-Barr virus BFRF3 Gene_生物学_自然科学_专业资料。VIROLOGICA SINICA,December 2013,28(6):368—372 D0I 10.1007/s ...
Infection frequency of Epstein-Barr virus in subgingival samples from patients with different pe_专业资料。维普资讯 http://www.cqvip.com 867 Wuea....
热门文档